Table 4

CXCR3 expression by cutaneous MZBCLs and other extranodal MZBCLs

CXCR3, no. (%)
Cutaneous MZBCLs 4/32 (13%)* 
Other extranodal MZBCLs 17/20 (85%) 
CXCR3, no. (%)
Cutaneous MZBCLs 4/32 (13%)* 
Other extranodal MZBCLs 17/20 (85%) 
*

The CXCR3+ tumors were the IgM+ CM04, CM13, CM43, and pt6.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal